Page last updated: 2024-11-04

sulfadiazine and Hydramnios

sulfadiazine has been researched along with Hydramnios in 1 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Research Excerpts

ExcerptRelevanceReference
"Congenital toxoplasmosis is a potentially serious infection which usually affects infants born to non immune women."1.32[Congenital toxoplasmosis: a new case of infection during pregnancy in an previously immunized and immunocompetent woman]. ( Baudon, JJ; Ducrocq, S; Gold, F; Lebas, F; Mégier, P; Mucignat, V; Paris, L, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lebas, F1
Ducrocq, S1
Mucignat, V1
Paris, L1
Mégier, P1
Baudon, JJ1
Gold, F1

Other Studies

1 other study available for sulfadiazine and Hydramnios

ArticleYear
[Congenital toxoplasmosis: a new case of infection during pregnancy in an previously immunized and immunocompetent woman].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2004, Volume: 11, Issue:8

    Topics: Angola; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Cesarean Section; Drug Therapy, Combin

2004